Market Cap 17.72B
Revenue (ttm) 7.68B
Net Income (ttm) 903.70M
EPS (ttm) N/A
PE Ratio 11.10
Forward PE 11.00
Profit Margin 11.77%
Debt to Equity Ratio 0.64
Volume 623,100
Avg Vol 2,177,848
Day's Range N/A - N/A
Shares Out 198.18M
Stochastic %K 37%
Beta 0.61
Analysts Sell
Price Target $101.78

Company Profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to fa...

Industry: Medical Devices
Sector: Healthcare
Phone: 574 373 3333
Address:
345 East Main Street, Warsaw, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:08 PM
Actionable Trade Alert for $ZBH: Market Context: $ZBH is currently trading at $90.23, below both the 30-day moving average (MA30) of $92.00 and the 50-day moving average (MA50) of $94.52, indicating a bearish trend. The RSI at 38.49 suggests that the stock is nearing oversold conditions, which may present a potential reversal opportunity. Directional Bias: Given the current price relative to the MAs and the RSI, we anticipate a potential upward correction towards the 60-day high of $106.88. The price is also within the range of the 60-day low of $85.33, providing a clear risk-reward setup. Trade Plan: - Suggested Entry: $90.50 - Stop Loss: $85.00 - Take Profit Targets: 1. $95.00 (5% ROI) 2. $100.00 (10.5% ROI) 3. $106.00 (17.5% ROI) This plan offers a favorable risk-reward ratio with a potential return of over 17% on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
DonCorleone77
DonCorleone77 Dec. 23 at 11:01 AM
$ZBH JPMorgan sees 2026 as 'pivotal year' for Zimmer Biomet JPMorgan thinks 2026 is set up to be a "pivotal year" for Zimmer Biomet. The analyst keeps a Neutral rating on the shares with a $100 price target. Investors want Zimmer to "deliver a boring, consistent, beat and raise year" where results outperform expectations, the analyst tells investors in a research note. After meeting with management, JPMorgan thinks the company's fundamentals are in "good shape, with portfolio gaps filled and plenty of opportunities for growth." It views Zimmer's 2026 as conservative and sees potential for a year for the stock.
0 · Reply
QeltharLiquidity
QeltharLiquidity Dec. 20 at 3:59 PM
$ZBH medtech large cap in a wide channel, better risk reward comes on pullbacks to support rather than chasing breakouts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:03 PM
Actionable Trade Alert for $ZBH: Market Context: $ZBH is currently trading at $90.4, with a low RSI of 21.29, indicating it is oversold. This suggests a potential reversal or upward movement. The stock is also below its 30-day moving average (MA30) of 91.72 and 50-day moving average (MA50) of 95.19, indicating bearish sentiment, but the significant distance from the 60-day high of 106.88 presents a recovery opportunity. Directional Bias: Given the oversold RSI and proximity to the 60-day low of 85.33, we anticipate a bullish reversal in the near term. Trade Plan: - Suggested Entry: $90.4 - Stop Loss: $85.0 (5.5% below entry) - Take Profit Targets: 1. $93.0 (Target 1: 2.9% ROI) 2. $97.0 (Target 2: 7.9% ROI) 3. $106.0 (Target 3: 17.3% ROI) This plan allows for a strong upside potential while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PnLFocusTrack_905
PnLFocusTrack_905 Dec. 18 at 5:24 PM
$ZBH medtech large cap, steady channel moves with shallow dips suggest slow institutional accumulation rather than hot momentum
0 · Reply
tkstockpicker
tkstockpicker Dec. 17 at 8:12 PM
$ZBH Sold this round, too slow
0 · Reply
MMM_invest
MMM_invest Dec. 17 at 3:35 PM
$NMTC Hurry up $ZBH , act accordingly... It will only get more expensive for you. Me personally would be satisfied with $5 per share
1 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 1:32 PM
$ZBH slips 1.6% post-collaboration news — but is a rebound expected? 🔄 The exclusive deal with OneStep enhances their mymobility Care Management Platform, promising surgeons improved recovery tracking post-joint replacement. With an 8.3% earnings yield, ZBH has the potential to bounce back stronger. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2805402/how-the-onestep-partnership-could-drive-growth-for-zbh-stock?cid=sm-stocktwits-2-2805402-body-25115&ADID=SYND_STOCKTWITS_TWEET_2_2805402_BODY_25115
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 12:32 PM
$ZBH makes a smart move in connected care — is this a growth catalyst? 🚀 Zimmer Biomet is teaming up with OneStep to integrate mobility analytics into mymobility, empowering surgeons and patients while pushing its connected care strategy forward in a meaningful way. See how this partnership could drive ZBH’s next phase of growth 👉 https://www.zacks.com/stock/news/2805402/how-the-onestep-partnership-could-drive-growth-for-zbh-stock?cid=sm-stocktwits-2-2805402-teaser-25114&ADID=SYND_STOCKTWITS_TWEET_2_2805402_TEASER_25114
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:49 AM
Actionable Trade Alert for $ZBH: Market Context: Currently, $ZBH is trading at $90.9, below both the 30-day MA of $92.43 and the 50-day MA of $95.51, indicating bearish momentum. The RSI at 41.08 suggests that the asset is approaching oversold conditions, which may lead to a potential reversal. Directional Bias: Given the current price is near the 60-day low of $85.33, there is a possibility for a bounce back. However, the proximity to the moving averages and the RSI indicates a cautious approach. Suggested Trade Plan: - Entry: $91.00 - Stop Loss: $88.00 (a risk of $3.00) - Take Profit Targets: 1. $94.00 (17% ROI) 2. $96.00 (22% ROI) 3. $106.00 (16.5% ROI) The first target aligns with the 30-day MA, while the second target approaches the 50-day MA. The third target is near the 60-day high, providing a substantial exit point. Trade cautiously and monitor market conditions closely. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Latest News on ZBH
Could Zimmer Biomet Stock Be Your Next Buy?

Nov 17, 2025, 8:55 AM EST - 5 weeks ago

Could Zimmer Biomet Stock Be Your Next Buy?


Time To Buy Zimmer Biomet Stock?

Nov 6, 2025, 11:15 AM EST - 7 weeks ago

Time To Buy Zimmer Biomet Stock?


Zimmer Biomet Announces Third Quarter 2025 Financial Results

Nov 5, 2025, 6:30 AM EST - 7 weeks ago

Zimmer Biomet Announces Third Quarter 2025 Financial Results


Zimmer Biomet Completes Acquisition of Monogram Technologies

Oct 7, 2025, 9:00 AM EDT - 2 months ago

Zimmer Biomet Completes Acquisition of Monogram Technologies


4 Stocks to Buy From a Top-Performing Fund Manager

Aug 12, 2025, 11:20 AM EDT - 4 months ago

4 Stocks to Buy From a Top-Performing Fund Manager

AMZN CRM NKE


Final Trades: Uber, Delta, Zimmer Holdings and Boeing

Jul 11, 2025, 2:21 PM EDT - 5 months ago

Final Trades: Uber, Delta, Zimmer Holdings and Boeing

BA UBER DAL


New vaccine panel meeting underway

Jun 26, 2025, 11:46 AM EDT - 6 months ago

New vaccine panel meeting underway

BDX BMY MRK UNH


Zimmer Biomet Announces First Quarter 2025 Financial Results

May 5, 2025, 6:30 AM EDT - 8 months ago

Zimmer Biomet Announces First Quarter 2025 Financial Results


Zimmer Biomet Completes Acquisition of Paragon 28

Apr 21, 2025, 9:00 AM EDT - 8 months ago

Zimmer Biomet Completes Acquisition of Paragon 28


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:08 PM
Actionable Trade Alert for $ZBH: Market Context: $ZBH is currently trading at $90.23, below both the 30-day moving average (MA30) of $92.00 and the 50-day moving average (MA50) of $94.52, indicating a bearish trend. The RSI at 38.49 suggests that the stock is nearing oversold conditions, which may present a potential reversal opportunity. Directional Bias: Given the current price relative to the MAs and the RSI, we anticipate a potential upward correction towards the 60-day high of $106.88. The price is also within the range of the 60-day low of $85.33, providing a clear risk-reward setup. Trade Plan: - Suggested Entry: $90.50 - Stop Loss: $85.00 - Take Profit Targets: 1. $95.00 (5% ROI) 2. $100.00 (10.5% ROI) 3. $106.00 (17.5% ROI) This plan offers a favorable risk-reward ratio with a potential return of over 17% on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
DonCorleone77
DonCorleone77 Dec. 23 at 11:01 AM
$ZBH JPMorgan sees 2026 as 'pivotal year' for Zimmer Biomet JPMorgan thinks 2026 is set up to be a "pivotal year" for Zimmer Biomet. The analyst keeps a Neutral rating on the shares with a $100 price target. Investors want Zimmer to "deliver a boring, consistent, beat and raise year" where results outperform expectations, the analyst tells investors in a research note. After meeting with management, JPMorgan thinks the company's fundamentals are in "good shape, with portfolio gaps filled and plenty of opportunities for growth." It views Zimmer's 2026 as conservative and sees potential for a year for the stock.
0 · Reply
QeltharLiquidity
QeltharLiquidity Dec. 20 at 3:59 PM
$ZBH medtech large cap in a wide channel, better risk reward comes on pullbacks to support rather than chasing breakouts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:03 PM
Actionable Trade Alert for $ZBH: Market Context: $ZBH is currently trading at $90.4, with a low RSI of 21.29, indicating it is oversold. This suggests a potential reversal or upward movement. The stock is also below its 30-day moving average (MA30) of 91.72 and 50-day moving average (MA50) of 95.19, indicating bearish sentiment, but the significant distance from the 60-day high of 106.88 presents a recovery opportunity. Directional Bias: Given the oversold RSI and proximity to the 60-day low of 85.33, we anticipate a bullish reversal in the near term. Trade Plan: - Suggested Entry: $90.4 - Stop Loss: $85.0 (5.5% below entry) - Take Profit Targets: 1. $93.0 (Target 1: 2.9% ROI) 2. $97.0 (Target 2: 7.9% ROI) 3. $106.0 (Target 3: 17.3% ROI) This plan allows for a strong upside potential while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PnLFocusTrack_905
PnLFocusTrack_905 Dec. 18 at 5:24 PM
$ZBH medtech large cap, steady channel moves with shallow dips suggest slow institutional accumulation rather than hot momentum
0 · Reply
tkstockpicker
tkstockpicker Dec. 17 at 8:12 PM
$ZBH Sold this round, too slow
0 · Reply
MMM_invest
MMM_invest Dec. 17 at 3:35 PM
$NMTC Hurry up $ZBH , act accordingly... It will only get more expensive for you. Me personally would be satisfied with $5 per share
1 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 1:32 PM
$ZBH slips 1.6% post-collaboration news — but is a rebound expected? 🔄 The exclusive deal with OneStep enhances their mymobility Care Management Platform, promising surgeons improved recovery tracking post-joint replacement. With an 8.3% earnings yield, ZBH has the potential to bounce back stronger. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2805402/how-the-onestep-partnership-could-drive-growth-for-zbh-stock?cid=sm-stocktwits-2-2805402-body-25115&ADID=SYND_STOCKTWITS_TWEET_2_2805402_BODY_25115
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 12:32 PM
$ZBH makes a smart move in connected care — is this a growth catalyst? 🚀 Zimmer Biomet is teaming up with OneStep to integrate mobility analytics into mymobility, empowering surgeons and patients while pushing its connected care strategy forward in a meaningful way. See how this partnership could drive ZBH’s next phase of growth 👉 https://www.zacks.com/stock/news/2805402/how-the-onestep-partnership-could-drive-growth-for-zbh-stock?cid=sm-stocktwits-2-2805402-teaser-25114&ADID=SYND_STOCKTWITS_TWEET_2_2805402_TEASER_25114
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:49 AM
Actionable Trade Alert for $ZBH: Market Context: Currently, $ZBH is trading at $90.9, below both the 30-day MA of $92.43 and the 50-day MA of $95.51, indicating bearish momentum. The RSI at 41.08 suggests that the asset is approaching oversold conditions, which may lead to a potential reversal. Directional Bias: Given the current price is near the 60-day low of $85.33, there is a possibility for a bounce back. However, the proximity to the moving averages and the RSI indicates a cautious approach. Suggested Trade Plan: - Entry: $91.00 - Stop Loss: $88.00 (a risk of $3.00) - Take Profit Targets: 1. $94.00 (17% ROI) 2. $96.00 (22% ROI) 3. $106.00 (16.5% ROI) The first target aligns with the 30-day MA, while the second target approaches the 50-day MA. The third target is near the 60-day high, providing a substantial exit point. Trade cautiously and monitor market conditions closely. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 11:23 AM
Baird updates rating for Zimmer Biomet Holdings ( $ZBH ) to Neutral, target set at 117 → 100.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 15 at 10:52 AM
$ZBH RSI: 48.08, MACD: -0.6581 Vol: 2.70, MA20: 92.78, MA50: 95.69 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:23 AM
Actionable Trade Alert for $ZBH: Market Context: $ZBH is currently trading at $91.59, positioned between its 60-day high of $106.88 and low of $85.33. The RSI at 48.08 indicates a neutral momentum, suggesting potential for upward movement if buying pressure increases. Directional Bias: The stock is below its 30-day MA of $92.72 and 50-day MA of $95.69, indicating a bearish short-term trend. However, given the proximity to the 60-day low, there may be an opportunity for a rebound. Trade Plan: - Suggested Entry: $91.59 - Stop Loss: $88.00 (approx. 3% risk) - Take Profit Targets: 1. TP1: $95.00 (approx. 3.4% gain) 2. TP2: $100.00 (approx. 9.1% gain) 3. TP3: $107.00 (approx. 16.7% gain) With a focus on a potential recovery from the recent lows, this trade offers a structured approach with a minimum 17% ROI on TP3. Monitor price action closely and adjust as necessary. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:16 PM
Actionable Trade Alert for $ZBH: Market Context: $ZBH is currently trading at $92.79, showing a strong position within its recent trading range. The RSI at 60.81 indicates bullish momentum but is not overbought, suggesting room for upward movement. The stock is below its 30-day moving average (MA30) of $93.0 and 50-day moving average (MA50) of $95.85, indicating potential for a reversal. Directional Bias: The stock is positioned between the 60-day high of $106.88 and low of $85.33, providing a clear range for potential gains. The ATR of 2.15 suggests moderate volatility, allowing for reasonable movement towards our targets. Suggested Trade Plan: - Entry: $92.79 - Stop Loss: $90.00 (2.99% below entry) - Take Profit Targets: 1. $95.00 (2.38% gain) 2. $100.00 (7.85% gain) 3. $108.00 (16.36% gain) This plan offers a potential ROI of over 17% at the third target. Execute with caution and monitor market conditions. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 9:07 PM
Citigroup has adjusted their stance on Zimmer Biomet Holdings ( $ZBH ), setting the rating to Neutral with a target price of 98 → 94.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:20 AM
Actionable Trade Alert for $ZBH: Market Context: $ZBH is currently trading at $92.27, showing a strong position within its recent range (60D High: $106.88, 60D Low: $85.33). The RSI at 59.45 indicates bullish momentum, suggesting potential for upward movement. Directional Bias: The current price is below both the 30-day MA (93.5) and the 50-day MA (96.08), indicating a potential rebound as it approaches these moving averages. The RSI supports this bias, as it is not yet overbought. Trade Plan: - Suggested Entry: $92.50 - Stop Loss: $89.50 (risking $3.00) - Take Profit Targets: 1. TP1: $95.00 (3.5% gain) 2. TP2: $98.00 (6.5% gain) 3. TP3: $108.00 (17% gain) This plan offers a solid risk-reward ratio, with TP3 providing a potential ROI of over 17%. Monitor the trade closely for any changes in momentum. https://privateprofiteers.com
0 · Reply
tkstockpicker
tkstockpicker Dec. 9 at 6:17 PM
$ZBH Back in
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:08 PM
Actionable Trade Alert for $ZBH: Market Context: $ZBH is currently trading at $92.27, showing a moderate bullish sentiment with an RSI of 60.49, indicating potential for upward momentum. The stock is below its 30-day moving average (MA30) of $93.84, suggesting a possible rebound. Directional Bias: The RSI indicates that the stock is neither overbought nor oversold, allowing for further upside. The proximity to the 60D high of $106.88 presents a favorable risk-reward scenario, while the 60D low of $85.33 provides a clear support level. Trade Plan: - Suggested Entry: $92.50 - Stop Loss: $89.50 (2.99% below entry) - Take Profit Targets: 1. $95.00 (2.68% gain) 2. $98.00 (5.66% gain) 3. $108.00 (16.87% gain) With these targets, we aim for a minimum of 17% ROI on the third target. Monitor the price action closely and adjust stop loss as necessary to lock in profits. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:08 AM
Actionable Trade Alert for $ZBH: Market Context: $ZBH is currently trading at $93.16, showing a moderate bullish sentiment with an RSI of 58.04, indicating potential for upward movement without being overbought. The price is below both the 30-day MA (94.5) and 50-day MA (96.36), suggesting a possible reversal opportunity as it approaches these moving averages. Directional Bias: The recent high of $106.88 and low of $85.33 over the last 60 days indicates a healthy range for potential gains. The ATR of 2.12 suggests volatility, allowing for significant price movements. Trade Plan: - Suggested Entry: $93.50 - Stop Loss: $90.00 (3.5% risk) - Take Profit Targets: 1. $98.00 (Target 1: 4.0% ROI) 2. $101.00 (Target 2: 8.3% ROI) 3. $109.00 (Target 3: 17.0% ROI) This plan allows for a balanced risk-reward ratio while targeting substantial returns. Monitor closely for price action around moving averages. https://privateprofiteers.com
0 · Reply
Ro_Patel
Ro_Patel Dec. 4 at 3:59 PM
BofA: Surgical robot market could grow steadily over the next decade, potentially driven by: 1) robotic surgery gradually becoming the standard of care 2) rising demand for precision & shorter recovery 3) next-generation technologies – such as remote surgery 4) greater robot autonomy to enhance surgeon’s efficiency 5) expansion into new disease areas to address unmet demand. In fact, BofA Global Research expects the global surgical robot market to reach $23B in FY25 & expand to $52B by FY30 $ISRG $MDT $SYK $ZBH --- IMHO Demand: 1) Aging population 2) Less invasive surgery 3) Hospital efficiency needs
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 10:41 AM
$ZBH Current Stock Price: $94.11 Contracts to trade: $95 ZBH Dec 19 2025 Call Entry: $1.89 Exit: $2.43 ROI: 29% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
tkstockpicker
tkstockpicker Nov. 25 at 8:58 PM
$ZBH All out and banked
0 · Reply